ImmunityBio, Inc. (FRA:26CA)
Germany flag Germany · Delayed Price · Currency is EUR
5.20
+0.29 (5.84%)
At close: Jan 30, 2026

ImmunityBio Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
5,1821,8053,0321,9422,127-
Market Cap Growth
205.50%-40.46%56.14%-8.68%--
Enterprise Value
5,6902,6653,5122,5042,357-
Last Close Price
5.202.694.584.545.46-
PS Ratio
73.64126.775388.888648.472589.53-
PB Ratio
-11.62-3.83-5.72-4.61-9.92-
EV/Sales Ratio
81.89187.096241.2011149.272870.55-
Debt / Equity Ratio
-1.65-1.62-1.51-1.61-2.66-2.33
Asset Turnover
0.190.030.000.000.000.00
Quick Ratio
5.102.784.630.220.861.44
Current Ratio
5.773.365.050.280.911.64
Return on Assets (ROA)
-36.89%-48.48%-52.11%-52.73%-57.48%-72.72%
Return on Capital Employed (ROCE)
-56.50%-104.90%-81.00%253.20%-317.70%-130.90%
Earnings Yield
-5.73%-22.13%-17.40%-20.07%-14.34%-
FCF Yield
-5.34%-21.30%-11.85%-20.03%-12.73%-
Buyback Yield / Dilution
-25.58%-37.71%-27.19%-2.74%-3.23%-2.93%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.